n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane has been researched along with 1,3-ditolylguanidine in 1 studies
| Studies (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Trials (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Recent Studies (post-2010) (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Studies (1,3-ditolylguanidine) | Trials (1,3-ditolylguanidine) | Recent Studies (post-2010) (1,3-ditolylguanidine) |
|---|---|---|---|---|---|
| 33 | 1 | 19 | 357 | 0 | 71 |
| Protein | Taxonomy | n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane (IC50) | 1,3-ditolylguanidine (IC50) |
|---|---|---|---|
| polyadenylate-binding protein 1 | Homo sapiens (human) | 19.8 | |
| Rev | Human immunodeficiency virus 1 | 8.312 | |
| Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 5.205 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.036 | |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 0.1816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H; Helmeste, DM; Li, M; Tang, SW | 1 |
1 other study(ies) available for n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane and 1,3-ditolylguanidine
| Article | Year |
|---|---|
Multiple [3H]-nemonapride binding sites in calf brain.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Benzamides; Binding, Competitive; Brain; Cattle; Cerebellum; Cerebral Cortex; Corpus Striatum; Dioxanes; Dopamine Agonists; Dopamine Antagonists; Guanidines; Haloperidol; In Vitro Techniques; Isotope Labeling; Narcotic Antagonists; Pentazocine; Piperidines; Propylamines; Pyrrolidines; Receptors, Dopamine D2; Receptors, sigma; Sulpiride; Tritium | 1997 |